
Q&A with Dr Gary Waanders Healthcare Research Director at Zeus Capital
Zeus Capital’s Dr Gary Waanders discusses Allergy Therapeutics plc in this exclusive interview with DirectorsTalk
Zeus Capital’s Dr Gary Waanders discusses Allergy Therapeutics plc in this exclusive interview with DirectorsTalk
Zeus Capital’s Dr Gary Waanders discusses Motif Bio PLC in this exclusive interview with DirectorsTalk
Deltex Medical Group’s Jonathan Shaw discusses their trading update & platform account RNS released today in this exclusive interview DirectorsTalk
Zeus Capital’s Robin Savage discusses City of London Investment Group PLC in this exclusive interview with DirectorsTalk
Northland Capital Partners’ Vadim Alexandre discusses Evgen Pharma PLC in this exclusive interview with DirectorsTalk
Hardman and Co’s Tony Williams discusses the housebuilding sector for 2016/2017: what companies did and didn’t do well, the resignation of David Ritchie CEO at Bovis Homes Group plc (LON:BVS), what happened in 2017 and what’s next for the sector in this exclusive interview with DirectorsTalk
Zeus Capital’s Mike Allen discusses Elegant Hotels Group PLC in this exclusive interview with DirectorsTalk
European Metals Holdings’ Keith Coughlan discusses the completion of their drill programme and the appointment of a Czech Country Manager in this exclusive interview with DirectorsTalk
FinnAust Mining’s Roderick McIllree discusses their latest Pituffik Work Programme update in this exclusive interview with DirectorsTalk
Gresham House Strategic’s Graham Bird discusses how 2016 went for them, standout investments, his view on prospects for the year, interesting sectors and stocks he likes the look of for 2017 in this exclusive interview with DirectorsTalk